Holen Sie sich die Stockscreener-App
11.65
0.60%
0.0703
Schlusskurs vom Vortag:
$11.58
Offen:
$11.6
24-Stunden-Volumen:
438.67K
Relative Volume:
0.34
Marktkapitalisierung:
$860.06M
Einnahmen:
$255.87M
Nettoeinkommen (Verlust:
$-103.27M
KGV:
-8.2574
EPS:
-1.4109
Netto-Cashflow:
$12.46M
1W Leistung:
+5.24%
1M Leistung:
-8.56%
6M Leistung:
-45.28%
1J Leistung:
-35.39%
1-Tages-Spanne:
$11.56
$11.76
1-Wochen-Bereich:
$11.11
$11.76
52-Wochen-Spanne:
$10.95
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
11.65 | 854.89M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
174.31 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
47.68 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.65 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.37 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.60 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
SDGR Technical Analysis & Stock Price Forecast - Intellectia AI
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
SchröDinger: Transition Pressure And Competition Offset Ecosystem Strength (NASDAQ:SDGR) - Seeking Alpha
Avoiding Lag: Real-Time Signals in (SDGR) Movement - news.stocktradersdaily.com
Schrodinger Inc Stock: Physics-Based Computing Leader in Drug Discovery and Materials Science for In - AD HOC NEWS
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Schrodinger (NASDAQ:SDGR) Sets New 52-Week LowTime to Sell? - MarketBeat
Vanguard disaggregates holdings; SDGR filing shows 0 shares (SDGR) - Stock Titan
Schrödinger Discontinues Clinical Program After Two Patient Deaths - MSN
Tudor Investment Corp ET AL Has $6.75 Million Position in Schrodinger, Inc. $SDGR - marketbeat.com
Transcript : Schrödinger, Inc. Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum, Mar-17-2026 09 - marketscreener.com
Schrodinger Conference: SDGR Targets Hosted Shift, Platform Adoption, EBITDA Profitability in 3 Years - Yahoo Finance
Discipline and Rules-Based Execution in SDGR Response - news.stocktradersdaily.com
Schrödinger (SDGR) Morgan Stanley 22nd Annual Global Healthcare Conference Summary - Quartr
Schrodinger downgraded at Citi after clinical program exit - MSN
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - msn.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 18, 2026 - BioSpace
Schrodinger reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SDGR: Analyst Michael Yee of UBS Lowers Price Target to $13, Mai - GuruFocus
UBS Group Cuts Schrodinger (NASDAQ:SDGR) Price Target to $13.00 - MarketBeat
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts By Investing.com - Investing.com India
Schrödinger at KeyBanc Forum: Strategic Shift to Hosted Contracts - Investing.com
SDGR: Strategic shift to hosted software, AI integration, and new products drive growth and industry impact - TradingView
Schrodinger (SDGR) Upgraded to Buy by B of A Securities | SDGR S - GuruFocus
Farallon Capital Management LLC Lowers Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Keybanc Maintains Schrödinger (SDGR) Overweight Recommendation - MSN
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrödinger Promotes Therese Abrams to Principal Accounting Officer - The Globe and Mail
Do Options Traders Know Something About Schrodinger Stock We Don't? - MSN
Schrödinger (NASDAQ: SDGR) appoints Therese Abrams as principal accounting officer - Stock Titan
Chemoinformatics Market Is Going to Boom Rapidly | Schrödinger Inc., PerkinElmer Inc., BioSolveIT GmbH - openPR.com
Schrödinger at Leerink Conference: Strategic Growth Amid Transition By Investing.com - Investing.com India
Schrödinger at Leerink Conference: Strategic Growth Amid Transition - Investing.com
Schrodinger2026 Funding Rounds & List of Investors - Tracxn
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock By Investing.com - Investing.com Nigeria
SDGR: Transition to ACV, new product launches, and materials science drive growth outlook - TradingView
SDGR: Transition to ACV, new product launches, and materials science expansion drive future growth - TradingView
Behavioral Patterns of SDGR and Institutional Flows - news.stocktradersdaily.com
Schrodinger Stock: Navigating Market Pressure Through Operational Discipline () - aktiencheck.de
Citigroup Downgrades Schrödinger (SDGR) - MSN
Does Schrodinger (SDGR) Have the Potential to Rally 40.43% as Wall Street Analysts Expect? - MSN
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock - Investing.com
Schrödinger Earnings Call: Growth Amid Hosted Transition - TipRanks
Ramy Farid Sells 3,661 Shares of Schrodinger (NASDAQ:SDGR) Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Insider Sells $16,653.00 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Insider Karen Akinsanya Sells 1,366 Shares - MarketBeat
Schrodinger (NASDAQ:SDGR) CFO Sells $21,039.90 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) EVP Kenneth Patrick Lorton Sells 1,222 Shares - MarketBeat
How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets - Yahoo Finance
Citigroup Inc. Grows Stake in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger, Inc. $SDGR Shares Sold by ARK Investment Management LLC - MarketBeat
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Schrodinger Inc-Aktie (SDGR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Herman Jenny | CAO |
Mar 06 '26 |
Sale |
12.84 |
608 |
7,808 |
34,804 |
| Jain Rachit | EVP & CFO |
Mar 05 '26 |
Sale |
12.90 |
1,631 |
21,033 |
52,596 |
| Tran Yvonne | EVP, CLO & CPO |
Mar 05 '26 |
Sale |
12.89 |
1,094 |
14,107 |
52,683 |
| Farid Ramy | President & CEO |
Mar 05 '26 |
Sale |
12.91 |
3,661 |
47,249 |
330,824 |
| Akinsanya Karen | See Remarks |
Mar 05 '26 |
Sale |
12.90 |
1,366 |
17,625 |
69,956 |
| Lorton Kenneth Patrick | EVP, CTO & COO, Software |
Mar 05 '26 |
Sale |
12.90 |
1,222 |
15,761 |
89,241 |
| Abel Robert Lorne | See Remarks |
Mar 04 '26 |
Sale |
12.81 |
1,300 |
16,653 |
55,897 |
0.61%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):